Dozens of global drugmakers are ramping up their investments in the United States in a bid to sidestep the planned tariffs on…
A new Japanese patent allowance follows a recent such US patent grant, strengthens protection around the organic solvent-free manufacturing process…
Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Researchers recognize that a large share of…
Beachgoers on the Gulf Coast in the U.S. have been urged to exercise caution in order to limit the risk of contracting a bacterial infection…
Earth Science Tech, a growing healthcare holding company, recently reported its Q1 2027 financial results, with key highlights including $9.0…
Doctors in Spain recently handled a fascinating yet terrifying case of a patient that developed brain cancer-like symptoms and was treated as such, but additional tests…
While immunotherapy is revolutionizing cancer therapy, response rates to these novel treatments are low and some patients that initially respond well end…
Regentis recently received European regulatory approval for a next-generation GelrinC manufacturing process that increases production yield by 400%. The company…
The company has advanced its VXA-222 bispecific antibody-drug conjugate (“bsADC”) program into the next stage of development following completion of…
As July came to an end, the United States reached an undesirable milestone: exceeding the total number of confirmed cases…